Abstract
Objective: To compare blood pressure lowering effects of angiotensin II type I receptor blocker candesartan cilexetil incomparison with calcium channel blocker amlodipine in essential hypertensive patients. Study design: Randomized, open-labeled,prospective comparative study. Place and duration: The study was carried out in the department of pharmacology and therapeutics,Basic Medical Sciences Institute (BMSI), Jinnah Post Graduate Medical Centre (JPMC), Karachi from July 2007 to January 2008.Subjects and methods: In this study (80) newly diagnosed essential hypertensive patients were enrolled and divided into two groups(DR1) and (DR2) respectively. DR1 patients received candesartan 16mg once a day and DR2 patients received Amlodipine 10mg once aday for 3 months duration. Results: The mean systolic blood pressure of DRI was 162.23 on day 0 which decreased to 141.05 on day 90,versus DR2 which decreased from 160.12 on day 0 to 140 on day 90. The mean diastolic blood pressure decreased significantly for DR 1group from 99.87 mmHg to 87 to 89. mmHg, versus DR2 which decreased from 98.5 to 86.25. All values of blood pressure have beentaken in mmHg. The results of this study were observed statistically significant. Conclusions: Candesartan cilexetil is a newer and saferalternative for the treatment of essential hypertensive patients in comparison to conventional antihypertensive treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
